The effect of steady‐state ropinirole on plasma concentrations of digoxin in patients with Parkinson’s disease
Open Access
- 1 February 1999
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 47 (2) , 219-222
- https://doi.org/10.1046/j.1365-2125.1999.00867.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled studyMovement Disorders, 1998
- The serum digoxin concentration: ten questions to ask.1997
- Bioequivalence requirements for generic productsPharmacology & Therapeutics, 1994
- Serum Concentration Monitoring of Cardiac GlycosidesClinical Pharmacokinetics, 1991
- Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonistPharmacology Biochemistry and Behavior, 1991
- Effect of cisapride and metoclopramide on digoxin bioavailabilityEuropean Journal of Drug Metabolism and Pharmacokinetics, 1986
- Decreased bioavailability of digoxin due to hypocholesterolemic interventions.Circulation, 1978
- Plasma digoxin concentration--its relation to digoxin dosage and clinical effects in patients with atrial fibrillation.Heart, 1972